Larotaxel
![]() | |
Systematic (IUPAC) name | |
---|---|
(2α,5β,7β,10β,13α)-4,10-Diacetoxy-1-hydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxy-7,19-cyclotax-11-en-2-yl benzoate | |
Identifiers | |
CAS Number |
156294-36-9 ![]() |
ATC code | None |
PubChem | CID 6918260 |
ChemSpider |
5293466 ![]() |
UNII |
TWQ8K8A81Y ![]() |
Chemical data | |
Formula | C45H53NO14 |
Molar mass | 831.90 g/mol |
![]() ![]() |
Larotaxel (code names XRP9881, RPR109881) is a drug of the taxane type that has been used experimentally in chemotherapy.[1]
References
|
This article is issued from Wikipedia - version of the Thursday, November 13, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.